Dwarkesh Ayurved Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 M
- Revenue Growth 50.20%
- Profit Growth -44.58%
- Ebitda -13.41%
- Net Worth 429.34%
- Total Assets 140.48%
About Dwarkesh Ayurved
Dwarkesh Ayurved Private Limited (DAPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 2012 and has a history of 13 years. Its registered office is in Bhilwara, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.50 M.
Man Kabra and Avichal Kabra serve as directors at the Company.
Company Details
-
Location
Bhilwara, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U24233RJ2012PTC037739
-
Company No.
037739
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jan 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Dwarkesh Ayurved?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Man Kabra
|
Director | 20-Dec-2016 | Current |
|
Avichal Kabra
|
Director | 04-Aug-2017 | Current |
Financial Performance of Dwarkesh Ayurved.
Dwarkesh Ayurved Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.2% increase. The company also saw a substantial fall in profitability, with a 44.58% decrease in profit. The company's net worth Soared by an impressive increase of 429.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dwarkesh Ayurved?
In 2020, Dwarkesh Ayurved had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dilkhush Natural Foods Private LimitedMan Kabra is a mutual person
-
Mewar Ayush Research And Development Association
Man Kabra is a mutual person
Charges (Loans)
₹6.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2021 | Hdfc Bank Limited | ₹6.50 M | Open |
How Many Employees Work at Dwarkesh Ayurved?
Unlock and access historical data on people associated with Dwarkesh Ayurved, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dwarkesh Ayurved, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dwarkesh Ayurved's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
